ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2007

A promising therapeutic approach for multiple sclerosis: recombinant T-cell receptor ligands modulate experimental autoimmune encephalomyelitis by reducing interleukin-17 production and inhibiting migration of encephalitogenic cells into the CNS.

Sushmita Sinha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.